When prostate cancer patients need therapy to reduce male hormone levels, delivering some of the treatment via a patch on the ...

The new drug is meant to treat specific types of advanced breast cancer which are resistant to hormone therapy.

A paper inadvertently published on the website of an ASCO conference revealed good results for mevrometostat in treating ...

The FDA approved Datroway to treat metastatic or unresectable HR+/HER2- breast cancer in people who have tried standard chemo ...

Discover why male breast cancer cases are rising, learn essential warning signs most men miss, and understand new treatment options that could save lives.

such as a hormone therapy drug. Your doctor may recommend hormone therapy if you have platinum-resistant endometrial cancer that’s progesterone receptor (PR) positive, estrogen receptor (ER ...

Your doctor may recommend chemo, hormone, or targeted therapy. You may receive a combination of therapies or something else entirely. Oncology (cancer) drugs include a range of therapies and ...

Dr. Debu Tripathy discusses the FDA approval of Enhertu in unresectable or metastatic hormone receptor HR+, HER2-low or -ultralow breast cancer.

Despite significant therapeutic advances, breast cancer remains a leading ... typically involves several years of hormone therapy. Although these drugs are better tolerated than chemotherapy ...

Despite significant therapeutic advances, breast cancer remains a leading ... typically involves several years of hormone therapy. Although these drugs are better tolerated than chemotherapy ...

Cell cycle re-entry of senescent breast cancer cells after CDK4/6 inhibition (CDK4/6i) constitutes a major source of disease ...

The European Medicines Agency has recommended three new medicines to treat breast and cervical cancer and ...